The results appeared to suggest that GHRP-2 may lead to a rise in circulating IGF-I levels, potentially ranging between 1.2 to 1.6 times the baseline levels
The STEP 1 extension data showed approximately two-thirds of total weight loss regained within one year of discontinuation, emphasizing the chronic nature of obesity and the need for sustained treatment in most cases
Known Side Effects and Risks to Be Aware Of The most common side effects are gastrointestinal including nausea, vomiting, and diarrhoea with additional class-associated risks including pancreatitis, gallbladder disease, and increased heart rate
Curex offers compounded semaglutide, a GLP-1 medication (not the same as the branded drugs), starting at $49/mo with no insurance and no prior authorization required
Safety Considerations and Who Should Evaluate Compounded Semaglutide Compounded semaglutide is not FDA-approved